MEGABOL OMA

PACK SIZE: 56aps.

• stimulates the growth of muscle tissue mass,
• anti-catabolic effect,
• increase in strength.

The OMA preparation   is the first product based on amino acid decarboxylation inhibitors (etracene) intended for humans. This process, also called metabolic sparing, was presented in scientific publications in 2003 (R. Vespalec et al.), in 2005 (H. Liedreman), and in 2007-09 the results of the work of a group of scientists with Dr. H. Różański were published, indicating the effectiveness of the method in fattening animals (7% increase in the final mass). The effectiveness of the metabolic sparing method (etracene) in sports is currently being determined.

No supplement available in the world yet uses the method described. OMA  is the first commercial preparation containing etracene.

Etracen stimulates the growth of muscle tissue mass by inhibiting the decarboxylation of amino acids and stimulating the digestion of proteins, as well as by sparing the metabolic amino acids and directing them to protein synthesis.

Etracen  inhibits the activity of transaminases (aminotransferase): alanine aminotransferase and asparate aminotransferase. It reduces the concentration of microsomal enzymes, including cytochrome P-450 and benzphetamine N-demethylase. Transaminases cause the transfer of amino groups between different amino acids (amino acid cores), which causes radical changes in the rate and type of metabolic pathways (catabolism or synthesis) of individual amino acids. The consequence of this is an increase in the level of alkaline phosphatase and free amino acids in the blood. This is a positive effect on metabolism, and the mechanism of the stimulating effect of isoquinoline alkaloids on body weight growth depends on it.

ETRACEN was first presented to manufacturers in its laboratory version during the FIBO 2011 trade fair, and the work on it was described in the English “Beef Magazine” this year. In Poland, eleven moderators of SFD and Body-Factory made the first attempt in history to use this agent on themselves, presenting changes in their figure as they went along. The preparation was available to a narrow group, mainly for the purpose of conducting efficacy analyses (for testers with arm circumference > 44 cm it is still available free of charge on the Discovery-Polska.com website).

Etracen lowers the concentration of toxic amines in the intestines and blood, helping the liver function. Cyclic amino acids, e.g. tryptophan, tyrosine, histidine, phenylalanine, proline are not excessively broken down into amines, but are incorporated into the construction of enzymatic building blocks, which significantly improves the protein balance. By inhibiting the development of putrefactive and fermentative bacteria, the concentration of harmful amines in the intestines and blood (cadaverine, putrescine, skatole, indole) is reduced. Amines, burdening the kidneys and liver, adversely affect the growth and development of the body. Amines that are formed, especially during high-protein nutrition, additionally burden the liver and nervous system. Amines, which are products of amino acids, are responsible for faster fatigue of working muscles, and their presence is additionally characterized by an unpleasant smell of feces. During the use of etracen, the amino acids taken are absorbed and used for the synthesis of enzymatic and structural proteins. The active ingredients of etracen reduce the unpleasant odor of feces resulting from the decarboxylation of amino acids, fermentation and putrefactive processes. Such unfavorable processes in the digestive tract can be noticed especially when consuming amino acid and protein supplements.

The knowledge about the possibility of eliminating amines using alkaloid inhibitors is relatively new. The influence of isoquinoline alkaloids on the transformation of mercapto compounds was described in 2003 (R. Vespalec, P. Bartak, V. Šimánek and M. Vlcková1). The works and publications on the practical

The applications of these compounds were conducted, among others, by Dr Henryk Rózanski2,o3 (the author of the composition of etracene).

Etracen has an anti-catabolic effect on amino acids and body proteins. When animals were given isoquinoline alkaloids contained in etracen, an increase in body weight of 7% of the final weight was observed (additional 1 kg for every 14 kg of weight)2,3,4. Due to such high effectiveness, these compounds were introduced as an alternative to antibiotic growth stimulants and coccidiostats banned since 20053. Actual results in humans are the subject of ongoing experiments.

Serving size: 1 cap.

Number of servings per package: 56

Package size: 56 caps.

[]*Ingredients per serving

1caps.

*Etracene

2.5mg

Isoquinoline alkaloids

-13-Methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium

-1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin -12-ium

-7-Methyl-6,8,9,16-tetrahydrobis[1,3]benzodioxolo[4,5-c:5′,6′-g]azecin-15(7H)- one

-1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol

*[Organic acids

700mg

-Hexanoic acid

-Octanoic acid

-1-octanecarboxylic acid

other

Fatty acids from coconut oil, Macleayae cardatae heart herb, Theobromae cacao cocoa seeds, Fructus Capsici annui fruit, Ilicis paraguarensis holly leaf, silica, magnesium stearate, gelatin capsule.

How to use:

1 capsule of the preparation 2x a day, regardless of training schedule, consume 0.5 hour before a light meal. Do not exceed the amount of 2 capsules a day.